cmAngio® vs DeepTek CXR Analyzer
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, cmAngio®, is an FDA-cleared AI solution specifically designed to detect Breast Arterial Calcifications (BAC) on mammograms, offering insights into cardiovascular health. In contrast, Tool B, DeepTek CXR Analyzer, is an FDA-cleared AI-powered CADe solution for chest X-ray analysis, assisting radiologists in detecting a broad range of lung, pleural, and cardiac pathologies. While both are AI tools for medical imaging with applications in cardiology and radiology, they target different imaging modalities and distinct clinical use cases.
Choose cmAngio® if…
Choose cmAngio® if your primary goal is to leverage existing mammography screenings to proactively assess women's cardiovascular health risk. This FDA-cleared AI software is ideal for integrating early detection of Breast Arterial Calcifications (BAC) into routine breast imaging workflows, providing valuable insights for preventative care without additional radiation or procedures.
View cmAngio® →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if you need an AI-powered solution to enhance the efficiency and accuracy of interpreting a wide range of chest X-ray pathologies. This FDA-cleared tool is best suited for radiology departments aiming to reduce radiologist workload and boost productivity by automatically identifying and highlighting suspicious regions across lung, pleural, and cardiac findings, including hardware.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Paid, out-of-pocket | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | DeepTek CXR Analyzer |
|---|---|---|
| Tool Name | cmAngiou00ae | DeepTek CXR Analyzer |
| Company | CureMetrix | DeepTek Medical Imaging Pvt |
| Primary Function | AI software for detecting Breast Arterial Calcifications (BAC) on mammograms | AI-powered CADe solution for chest X-ray analysis, detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies |
| Key Features | AI-based detection of Breast Arterial Calcifications (BAC); Processes FFDM and DBT exams; Provides visualization of BAC location on a scorecard; Enables BAC identification and reporting without additional radiation or procedures; Compatible with any DICOM-compliant viewer; Adjustable operating point; Quick and easy installation; Cybersecure and HIPAA-compliant | AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays; Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware; Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs); Seamless DICOM-based PACS integration; Intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive'; Reduces radiologist workload by 30-50% and boosts productivity by 2x-3x; Generates secondary capture DICOM with AI output; Compatible with various X-ray modalities |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and DeepTek CXR Analyzer.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
cmAngiou00ae by CureMetrix is FDA-cleared AI software specifically designed for detecting Breast Arterial Calcifications (BAC) on mammograms, including both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams, to provide insights into cardiovascular health. DeepTek CXR Analyzer is an FDA-cleared AI-powered CADe solution for chest X-ray analysis, assisting radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, as well as hardware.
DeepTek CXR Analyzer operates on a pay-per-use pricing model and can be acquired as a technology offering or an AI-assisted reporting service. For cmAngiou00ae, pricing details are not publicly available, though limited-time offers for no-cost implementation and service may be an option upon contacting the vendor.
cmAngiou00ae is specialized in the AI-based detection and visualization of Breast Arterial Calcifications (BAC) on mammograms. DeepTek CXR Analyzer provides computer-assisted detection (CADe) for 28 findings, encompassing lung, pleural, cardiac pathologies, and hardware on chest X-rays.
cmAngiou00ae is compatible with any DICOM-compliant viewer and is designed for quick and easy installation, typically less than an hour. DeepTek CXR Analyzer offers seamless DICOM-based PACS integration, whether on-premise or cloud-based, and generates secondary capture DICOM with AI output for easy interpretation.
cmAngiou00ae enables BAC identification and reporting without requiring additional radiation or procedures, and it offers an adjustable operating point to meet clinical goals. DeepTek CXR Analyzer aims to reduce radiologist workload by 30-50% and boost productivity by 2x-3x by automatically identifying, categorizing, and highlighting suspicious regions and intelligently segregating scans into 'AI Finding-Negative' and 'AI Finding-Positive'.